Morphic Holding Analyst Ratings
Morphic Holding Acquisition Prospects: A Balanced Hold Rating Amid Lilly's Offer and Pipeline Potential
Morphic Holding (MORF) Was Downgraded to a Hold Rating at RBC Capital
Analysts Conflicted on These Healthcare Names: HilleVax, Inc (HLVX), UnitedHealth (UNH) and Morphic Holding (MORF)
Favorable Outlook for Eli Lilly's Acquisition of Morphic Holding With Strong Prospects for MORF-057
Morphic Holding (MORF) Was Downgraded to a Hold Rating at TD Cowen
Analysts Offer Insights on Healthcare Companies: AstraZeneca (AZN), Accolade (ACCD) and Morphic Holding (MORF)
Stifel Nicolaus Remains a Hold on Morphic Holding (MORF)
Morphic Holding (MORF) Gets a Buy From RBC Capital
Morphic Holding's Buy Rating Affirmed: Promising Trials and Strong Financial Outlook
Analysts Offer Insights on Healthcare Companies: MoonLake Immunotherapeutics (MLTX) and Morphic Holding (MORF)
Morphic Holding: A Strong Buy on Robust Financials and Promising Clinical Trials
Morphic Holding Analyst Ratings
Morphic Holding: Strong Financials and Promising Clinical Trials Reinforce Buy Rating
Analysts Offer Insights on Healthcare Companies: Morphic Holding (MORF) and Vertex Pharmaceuticals (VRTX)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Celldex (CLDX), Abbott Labs (ABT) and Morphic Holding (MORF)
Morphic Holding's Buy Rating Affirmed on Strong Clinical and Financial Prospects
Analysts Offer Insights on Healthcare Companies: Kymera Therapeutics (KYMR) and Morphic Holding (MORF)
BTIG Remains a Hold on Morphic Holding (MORF)
Morphic Holding Analyst Ratings
No Data